lometrexol

Drug Overview

Lometrexol is a special cancer-fighting medicine that belongs to a group of drugs called antimetabolites or antifolates. It is designed to act as a Targeted Therapy. It targets specific chemical pathways that cancer cells need to survive and grow. By starving the cancer cells of essential building blocks, lometrexol helps stop the spread of tumors.

• Generic name: Lometrexol (also known as lometrexol sodium)
• US Brand names: None (Currently known by research names like LY264618 or T 64)
• Drug Class: Antifolate, Antimetabolite, Purine Biosynthesis Inhibitor
• Route of Administration: Intravenous infusion (given through a needle into a vein)
• FDA Approval Status: Investigational. This means it is not yet approved by the US Food and Drug Administration for general use and is only given to patients taking part in clinical trials.

What Is It and How Does It Work? (Mechanism of Action)

Lometrexol works as a highly specific Targeted Therapy against cancer cells. To multiply, cancer cells must constantly build new DNA and RNA. To build these, the cells need basic building blocks called purines, which make up energy molecules like ATP and GTP.

Here is how the drug works at the molecular level:

Inside the cell, there is an important enzyme called glycinamide ribonucleotide formyltransferase, or GARFT for short. This enzyme is responsible for the very first steps of making new purines from scratch. Lometrexol is designed to look exactly like the natural chemicals the GARFT enzyme normally uses.

When the drug enters the cancer cell, it binds to the GARFT enzyme and blocks it completely. Because the enzyme is blocked, the cancer cell can no longer make ATP or GTP. Without these energy molecules, the cell cannot make new DNA. This forces the cancer cell to get stuck in the S phase of its life cycle. Eventually, the severe starvation of building blocks triggers a self-destruct signal in the cancer cell, leading to a natural cell death called apoptosis.

FDA-Approved Clinical Indications

Since lometrexol is still an investigational drug, it does not have official FDA-approved uses yet. However, it is being tested in clinical trials for specific conditions.

Oncological uses (Investigational):

• Non-small cell lung cancer.
• Metastatic breast cancer.
• Advanced solid tumors that do not respond to older folate drugs like methotrexate.
• Acute myeloid leukemia (in new combination studies).
• Urothelial carcinoma (bladder cancer).

Non oncological uses:

• None at this time.

Dosage and Administration Protocols

Because lometrexol is used in clinical trials, the dose depends on the exact study the patient is joining. Doctors also learned that patients must take a daily folic acid vitamin supplement to protect their healthy cells from the drug.

Dose Adjustments:

If a patient has kidney problems (renal insufficiency), the dose must be lowered or delayed. This is because the kidneys are responsible for clearing the drug from the body. If the kidneys do not work well, the drug will build up and cause severe damage to the bone marrow. Dose adjustments may also be needed for liver issues (hepatic insufficiency), which will be monitored by the cancer care team.

Clinical Efficacy and Research Results

Recent clinical research from 2020 to 2025 has focused on combining lometrexol with other new cancer drugs. In the past, when used alone, lometrexol showed a modest ability to shrink solid tumors, but its side effects were too harsh.

Today, scientists are finding that lometrexol works very well as a sensitizing agent. For example, recent 2024 and 2025 studies on acute myeloid leukemia showed that combining lometrexol with an apoptosis drug called venetoclax created a highly synergistic effect. This means the two drugs working together killed far more leukemia cells than either drug alone. In animal models, this combination significantly extended overall survival rates compared to standard treatments.

Similarly, in 2025 studies for metastatic breast cancer, researchers found that using lometrexol alongside hormone therapies or cell cycle blockers (like CDK4 and CDK6 inhibitors) strongly stopped tumor growth. While large-scale human survival numbers are not yet available for these new combinations, the early results show that blocking the purine pathway with lometrexol makes hard-to-treat cancers much weaker and easier to destroy.

Safety Profile and Side Effects

Lometrexol is a powerful drug that can affect healthy, fast-growing cells in the body, especially in the bone marrow and mouth.

Common side effects (Occurring in greater than 10 percent of patients):

• Decreased blood platelets (thrombocytopenia), which causes easy bruising and bleeding.
• Decreased white blood cells (neutropenia), which raises the risk of getting sick.
• Mouth sores and swelling (mucositis).
• Feeling very tired and weak (fatigue).
• Nausea and loss of appetite.

Serious adverse events:

• Severe, cumulative bone marrow suppression. If the drug builds up over time, it can stop the bone marrow from making any new blood cells, leading to life-threatening bleeding or severe infections.

Black Box Warning:

Because it is not officially approved, lometrexol does not have a formal FDA Black Box Warning. However, clinical trial rules come with a strict warning: severe, life-threatening blood toxicity will happen if the patient does not take daily folic acid supplements.

Management strategies:

Doctors will never start this drug unless the patient has taken a folic acid supplement every day for a full week before the first infusion. If mouth sores or low blood counts happen, the doctor will pause the treatment until the body heals. Doctors may also give special medicines to help boost white blood cell growth if the levels drop too low.

Connection to Stem Cell and Regenerative Medicine (If Applicable)

Research Areas:

Because lometrexol heavily damages the bone marrow, scientists are looking at ways to protect healthy blood stem cells during treatment. In recent leukemia studies, researchers are using lometrexol to specifically target and starve leukemic stem cells, which are the root cause of the cancer, while trying to spare normal, healthy stem cells. Additionally, the growing field of regenerative medicine is studying how replacing a patient’s damaged bone marrow with healthy stem cells might allow doctors to safely use stronger, more effective doses of drugs like lometrexol to fight aggressive solid tumors without permanent damage.

Patient Management and Practical Recommendations

Keeping patients safe is the top priority when using investigational drugs like lometrexol.

Pre-treatment tests to be performed:

• A complete blood count test to check white blood cell, red blood cell, and platelet levels.
• Kidney function tests to make sure the body can flush out the drug safely.
• Liver function tests.
• Blood tests to check the body’s natural vitamin levels, like folate and vitamin B12.

Precautions during treatment:

• Patients will be watched closely for any signs of an infection, like a fever or chills.
• Women of childbearing age must use strict birth control, as this drug can severely harm an unborn baby.

Do’s and Don’ts list:

• Do take your folic acid vitamin exactly as your doctor tells you to, every single day.
• Do call your doctor right away if you get a fever, notice unusual bleeding, or have deep pain in your mouth.
• Do drink plenty of water to help your kidneys clear the medicine.
• Do use a very soft toothbrush to prevent your gums from bleeding.
• Do not take any extra vitamins or herbal supplements without asking your doctor first, as some might interfere with how the drug works.
• Do not spend time around sick people or large crowds while your immune system is weak.

Legal Disclaimer

The medical information provided in this guide is for educational and informational purposes only and is not meant to replace professional medical advice, diagnosis, or treatment. Lometrexol is currently an investigational drug and is not approved by the FDA for general public use. It is only available through clinical trials. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition, clinical trial options, or cancer treatments. Do not disregard professional medical advice or delay seeking it because of something you have read in this material.